Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
There is an increasing interest in the treatment of mental disorders such as depression using repetitive transcranial magnetic stimulation (rTMS). Treatment guidelines for the application of rTMS are available, but they focus primarily on scientific evidence for efficacy and tolerability. Other aspects that are relevant for the training of practitioners, such as implementation in the national health system as well as organizational, formal, and practical aspects, are not covered in detail in these guidelines. Here, we present an overview of German rTMS courses and present training materials for the hands-on workshop of the German Society for Brain Stimulation in Psychiatry [Deutsche Gesellschaft für Hirnstimulation in der Psychiatrie (DGHP) e.V.] in German and English as an example. Publishing national standard operating procedures is important in order to harmonize rTMS practice all over the world.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12371536 | PMC |
| http://dx.doi.org/10.3389/fpsyt.2025.1490039 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Ultrasound system for precise neuromodulation of human deep brain circuits.
Nat Commun
September 2025
Department of Medical Physics and Biomedical Engineering, University College London, London, UK.
We introduce an advanced transcranial ultrasound stimulation (TUS) system for precise deep brain neuromodulation, featuring a 256-element helmet-shaped transducer array (555 kHz), stereotactic positioning, individualised planning, and real-time fMRI monitoring. Experiments demonstrated selective modulation of the lateral geniculate nucleus (LGN) and connected visual cortex regions. Participants showed significantly increased visual cortex activity during concurrent TUS and visual stimulation, with high cross-individual reproducibility.
View Article and Find Full Text PDFLetter to the editor regarding: "Lack of early reduction in depression severity predicts treatment non-response with 10 Hz and accelerated theta burst repetitive transcranial magnetic stimulation in treatment-resistant depression" by Nguyen et al. (2025).
J Affect Disord
September 2025
AIZH Statistics, Melbourne, Australia. Electronic address:
Beta Rhythm Predicts Treatment Response to Deep Transcranial Magnetic Stimulation in Patients with Treatment-Resistant Obsessive-Compulsive Disorder.
Clin EEG Neurosci
September 2025
Department of Psychiatry, NPI Brain Hospital, Uskudar University, Istanbul, Turkey.
IntroductionObsessive-compulsive disorder (OCD) affects 1.1-1.8% of the population, and adult females are more likely to suffer from it.
View Article and Find Full Text PDFA multi-modal approach for the treatment of non-fluent/agrammatic variant of Primary Progressive Aphasia.
Brain Commun
September 2025
Neuropsychology Unit, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia 25125, Italy.
The non-fluent/agrammatic variant of primary progressive aphasia is a neurodegenerative disorder characterized by effortful language production and impaired comprehension of grammatically complex sentences. Recently, interest in non-pharmacological interventions has increased, particularly regarding techniques that allow for non-invasive brain stimulation, such as transcranial direct current stimulation. The main purpose of this study was to investigate whether the use of anodal transcranial direct current stimulation applied to the dorsolateral prefrontal cortex during individualized language training for 25 min a day at 5 days a week for 2 weeks would lead to significant oral naming improvements in patients with agrammatic variant of primary progressive aphasia.
View Article and Find Full Text PDFPharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials.
Acta Psychiatr Scand
September 2025
Department of Psychiatry, McGill University Health Centre, Allan Memorial Institute, Quebec, Canada.
Background: Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non-psychological) strategies to address Cognitive Impairment Associated with Schizophrenia (CIAS).
View Article and Find Full Text PDF